Talk to your doctor about side effects and dosing Incorrect GLP-1 dosing has resulted in hospitalizations
In half of the trials, the rule was the same as in the previous trial (Repeat trial), and in the other half, the rule switched (Switch trial) based on a pseudo-randomized sequence
The importance of GLP-1 therapies for type 2 diabetes and CVD Today it is well established that excessive body fat together with lack of regular physical activity, together with a genetic predisposition, are the main causes of type 2 diabetes, contributing as well to a substantial proportion of cardiovascular diseases, cancers, and other chronic degenerative diseases
doi: 10.1038/npp.2016.246 188 BeiroaDImbernonMGallegoRSenraAHerranzDVillarroyaFet al
AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk